Nathanael R Fillmore

25PUBLICATIONS
81CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPattern recognitionInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 17, 2026
Survival Outcomes by Frailty and Comorbidities in Veterans Treated With Abiraterone and Enzalutamide for Metastatic Castration-Resistant Prostate Cancer.

|Jul 21, 2026
Evolution of real-world frontline treatment patterns in multiple myeloma.

|Jul 16, 2026
Abiraterone or Enzalutamide for Patients With Metastatic Castration-Sensitive Prostate Cancer: A Nationwide Veterans Affairs Study.

|May 29, 2026
Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular Risk.

|Aug 07, 2025
Automated Extraction of Imaging and Pathology Data From Diverse Prostate Cancer Electronic Records.

John M Culnan, Sergey D Goryachev, John R Bihn

|Oct 29, 2024
Lymphopenia predicts poor outcomes in newly diagnosed multiple myeloma.

Grace M Ferri, Cenk Yildirim, Nhan V Do

Pageof 5

Frequent Collaborators

12 joint publications

Nhan V Do

9 joint publications

Jennifer La

5 joint publications

Mary T Brophy

5 joint publications

Clark DuMontier